We use cookies for a better user experience. Read our Privacy Policy
I Agree
Drug Eluting Balloon Market
Drug-eluting balloons refer to semi-compliant angioplasty balloons that are coated with anti-proliferative medications and are dispersed in the walls of blood arteries following balloon inflation, which is typically done at minimal pressures. These balloons greatly reduce cellularity and remove the need for repeated vascularization. The increasing vascular disease rates, increased product advancements, and rising elderly population are all contributing to increasing demand for the drug-eluting balloon in the healthcare industry. However, the global drug eluting balloon market is predicted to develop slowly owing to the high cost of processes and goods, as well as tight regulatory rules.
Over the last decade, the healthcare infrastructure has seen significant changes as technology has advanced and healthcare research has exploded. Some of the causes driving demand for drug eluting balloon catheters are increasing incidences of obesity, an aging population, and a rise in occurrence of coronary artery disease. Stents that are utilized with a balloon catheter are referred to as balloon expandable stents, as opposed to self-expandable stents, which are often composed of nitinol alloy.
The global drug eluting balloon market is also benefiting from the increasing adoption of angioplasty balloons for patients who do not gain from percutaneous coronary intervention (PCI). Governments and other organizations are increasingly supporting research and providing financing to further develop drug eluting balloon catheters.
Drug eluting devices are used to lessen the incidence of restenosis and are most commonly connected with cardiac problems. Over the next 10 years, the market for peripheral drug-coated balloon catheters is expected to expand at a stable growth rate. As the benefits of drug-eluting balloon catheters are discovered and treatments become more inexpensive, the use of these catheters for peripheral artery operations is expected to rise.
Demand for coronary artery disease drug eluting balloon catheters is expected to account for over 80% of market share when it comes to value in the indication segment. Despite a small market share, the demand for drug-eluting balloon catheters for peripheral vascular disease is expected to grow at a stable CAGR in the years to come. With additional angioplasty balloons being studied and manufactured, sales of peripheral drug-coated balloon catheters are expected to rise as well.
Cardiovascular illnesses are a serious public-health concern. Peripheral artery disease (PAD) is a prevalent kind of peripheral vascular disease that affects persons over the age of 65 years. PAD causes the walls of arteries to thin, slowing blood flow. Although it most usually affects the peripheral areas, it can also damage the arteries that bring blood from the head to the heart, kidneys, and stomach. Given the rising prevalence of cardiovascular illnesses, it's critical to comprehend the elements that influence the extent of the diseases and the effective treatment choices available. A number of governmental and private players are making serious efforts through various initiatives in reducing the prevalence of cardiovascular disease. Governments as well as physicians and in industrialized nations have begun to inform the common people about PAD.
Every September, medical device firms, doctors, payers, and health care providers in the U.S. commemorate 'PAD Awareness Month.' During the awareness initiative, they strive to inform people about the ill effects of PAD and how to manage it. Several government agencies are funding research groups to help them produce drug-eluting balloons that are more successful in treating cardiovascular disorders. In the forthcoming years, this is anticipated to boost the global drug eluting balloon market.
North America region is expected to account for a prominent share in the global drug eluting balloon market. High rate of treatment as well as diagnosis of cardiovascular illnesses and increasing spending on healthcare is anticipated to augur well for the drug eluting balloon market in North America. Besides, greater penetration of innovative products along with favorable reimbursement policies is expected to drive sales growth in the regional market.
However, the expiration of TPT reimbursement on medication eluting balloons in December 2017 and ' tight regulatory system in the U.S. are expected to limit the drug eluting balloon market's growth in North America over the next two to three years. Due to the growing senior population, need for higher quality of care, and rise in the prevalence of cardiovascular illnesses in the area, the drug eluting balloon market in Asia Pacific is expected to provide substantial potential throughout the projected period.
The global drug eluting balloon market has been segmented as follows:
|
Product |
|
|
Technology
|
|
|
End-user |
|
|
Region |
|
The global drug eluting balloon market was worth US$ 420 Mn and is projected to reach a value of US$ 1800 Mn by the end of 2026
Drug eluting balloon market is anticipated to grow at a CAGR of 18% during the forecast period
North America accounted for a major share of the global drug eluting balloon market
Drug eluting balloon market is driven by increasing incidences of obesity, an aging population, and a rise in occurrence of coronary artery disease
Key players in the global drug eluting balloon market include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Drug Eluting Balloon Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Reimbursement Scenario
5.2. Cardiovascular Disease Prevalence
5.3. Key Mergers & Acquisitions
5.4. Key Market Trends
6. Global Drug Eluting Balloon Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2016–2026
6.3.1. Coronary Drug Eluting Balloon
6.3.2. Peripheral Drug Eluting Balloon
6.3.3 Others
6.4. Market Attractiveness, by Product Type
7. Global Drug-Eluting Balloon Market Analysis and Forecast, by Drug Coating Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
7.3.1. Paccocath
7.3.2. FreePac
7.3.3. TransPax
7.3.4. EnduraCoat
7.3.5. Others
7.4. Market Attractiveness, by Drug Coating Technology
8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Cath Labs
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Drug Eluting Balloon Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2016–2026
10.2.1. Coronary Drug Eluting Balloon
10.2.2. Peripheral Drug Eluting Balloon
10.2.3. Others
10.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
10.3.1. Paccocath
10.3.2. FreePac
10.3.3. TransPax
10.3.4. EnduraCoat
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Cath Labs
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Drug Coating Technology
10.6.3. By End-user
10.6.4. By Country
11. Europe Drug Eluting Balloon Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product Type, 2016–2026
11.2.1. Coronary Drug Eluting Balloon
11.2.2. Peripheral Drug Eluting Balloon
11.2.3 Others
11.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
11.3.1. Paccocath
11.3.2. FreePac
11.3.3. TransPax
11.3.4. EnduraCoat
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Cath Labs
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Drug Coating Technology
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product Type, 2016–2026
12.2.1. Coronary Drug Eluting Balloon
12.2.2. Peripheral Drug Eluting Balloon
12.2.3. Others
12.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
12.3.1. Paccocath
12.3.2. FreePac
12.3.3. TransPax
12.3.4. EnduraCoat
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Cath Labs
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Drug Coating Technology
12.6.3. By End-user
12.6.4. By Country
13. Latin America Drug Eluting Balloon Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product Type, 2016–2026
13.2.1. Coronary Drug Eluting Balloon
13.2.2. Peripheral Drug Eluting Balloon
13.2.3 Others
13.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
13.3.1. Paccocath
13.3.2. FreePac
13.3.3. TransPax
13.3.4. EnduraCoat
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Cath Labs
13.4.3. Others
13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Drug Coating Technology
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Drug-Eluting Balloon Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Product Type, 2016–2026
14.2.1. Coronary Drug Eluting Balloon
14.2.2. Peripheral Drug Eluting Balloon
14.2.3 Others
14.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
14.3.1. Paccocath
14.3.2. FreePac
14.3.3. TransPax
14.3.4. EnduraCoat
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Cath Labs
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Drug Coating Technology
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1.Market Player – Competition Matrix (by Tier and Size of companies)
15.2.Market Share Analysis, by Company (2017)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Bayer AG
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Product Portfolio
15.4.1.3. SWOT Analysis
15.4.1.4. Strategic Overview
15.4.1.5. Financial Overview
15.4.2. Medtronic
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Product Portfolio
15.4.2.3. SWOT Analysis
15.4.2.4. Strategic Overview
15.4.2.5. Financial Overview
15.4.3. B. Braun Melsungen AG
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Product Portfolio
15.4.3.3. SWOT Analysis
15.4.3.4. Strategic Overview
15.4.3.5. Financial Overview
15.4.4. Cook Medical, Inc.
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Product Portfolio
15.4.4.3. SWOT Analysis
15.4.4.4. Strategic Overview
15.4.4.5. Financial Overview
15.4.5. Boston Scientific Corporation
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Product Portfolio
15.4.5.3. SWOT Analysis
15.4.5.4. Strategic Overview
15.4.5.5. Financial Overview
15.4.6. Becton, Dickinson and Company
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Product Portfolio
15.4.6.3. SWOT Analysis
15.4.6.4. Strategic Overview
15.4.6.5. Financial Overview
15.4.7. EuroCor
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Product Portfolio
15.4.7.3. SWOT Analysis
15.4.7.4. Strategic Overview
15.4.7.5. Financial Overview
15.4.8. Terumo Corporation
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Product Portfolio
15.4.8.3. SWOT Analysis
15.4.8.4. Strategic Overview
15.4.8.5. Financial Overview
15.4.9. Koninklijke Philips N.V
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Product Portfolio
15.4.9.3. SWOT Analysis
15.4.9.4. Strategic Overview
15.4.9.5. Financial Overview
15.4.10. Other Prominent Players
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Product Portfolio
15.4.10.3. SWOT Analysis
15.4.10.4. Strategic Overview
15.4.10.5. Financial Overview
List of Tables
Table 1: Key Mergers and Acquisitions on Drug Eluting Balloon
Table 2: Snapshot of Ongoing Research on Drug Eluting Balloon
Table 3: Recent Patents on Drug Eluting Balloon
Table 4: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
Table 5: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 6: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 10: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 11: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 14: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 15: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
Table 17: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
Table 18: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 19: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 20: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
Table 21: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
Table 22: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 23: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 24: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region,
Table 25: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 26: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 27: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 1: Global Drug Eluting Balloon Market Size (US$ Mn) and Distribution, by Geography, 2017 and 2026
Figure 2: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment, 2017
Figure 3: Global Drug Eluting Balloon Market (US$ Mn), by Key Segment and Market Share (%), 2017
Figure 4: Global Drug Eluting Balloon Market (US$ Mn), by Market Share (%), 2017
Figure 5: Global Drug Eluting Balloon Market (US$ Mn), by Region (%), 2017
Figure 6: Global Drug Eluting Balloon Market Opportunity Map, by Product Type
Figure 7: Global Drug Eluting Balloon Market Opportunity Map, by Drug Coating Technology
Figure 8: Global Drug Eluting Balloon Market Opportunity Map, by End-user
Figure 9: Key Industry Evolution/Developments
Figure 10: Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
Figure 11: Global Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
Figure 12: Global Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
Figure 13: Coronary Drug Eluting Balloon Segment
Figure 14: Peripheral Drug Eluting Balloon Segment
Figure 15: Others Segment
Figure 16: Global Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
Figure 17: Global Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
Figure 18: Paccocath Segment
Figure 19: TransPax Segment
Figure 20: FreePac Segment
Figure 21: EnduraCoat Segment
Figure 22: Others Segment
Figure 23: Global Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
Figure 24: Global Drug Eluting Balloon Market Attractiveness, End-user 2018-2026
Figure 25: Hospitals and ASCs Segment
Figure 26: CATH Labs segment
Figure 27: Others Segment
Figure 28: Global Drug Eluting Balloon Market Value Share, by Region, 2017 and 2026
Figure 29: Global Drug Eluting Balloon Market Attractiveness, Region
Figure 30: North America Drug Eluting Balloons Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 31: North America Drug Eluting Balloon Market Value Share, by Country, 2017 and 2026
Figure 32: North America Drug Eluting Balloon Market Attractiveness, by Country, 2018–2026
Figure 33: North America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
Figure 34: North America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026
Figure 35: North America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
Figure 36: North America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026
Figure 37: North America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
Figure 38: North America Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026
Figure 39: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 40: Europe Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 41: Europe Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 42: Europe Drug Eluting Balloons Market Value Share, by Product Type, 2017 and 2026
Figure 43: Europe Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026
Figure 44: Europe Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
Figure 45: Europe Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026
Figure 46: Europe Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
Figure 47: Europe Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026
Figure 48: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
Figure 49: Asia Pacific Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 50: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026
Figure 51: Asia Pacific Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
Figure 52: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
Figure 53: Asia Pacific Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
Figure 54: Asia Pacific Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
Figure 55: Asia Pacific Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
Figure 56: Asia Pacific Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026
Figure 57: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
Figure 58: Latin America Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 59: Latin America Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018-2026
Figure 60: Latin America Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
Figure 61: Latin America Drug Eluting Balloon Market Attractiveness, by Product Type, 2018-2026
Figure 62: Latin America Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
Figure 63: Latin America Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018-2026
Figure 64: Latin America Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
Figure 65: Latin America Drug Eluting Balloon Market Attractiveness, by End-user, 2018-2026
Figure 66: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 67: Middle East & Africa Drug Eluting Balloon Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 68: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 69: Middle East & Africa Drug Eluting Balloon Market Value Share, by Product Type, 2017 and 2026
Figure 70: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Product Type, 2018–2026
Figure 71: Middle East & Africa Drug Eluting Balloon Market Value Share, by Drug Coating Technology, 2017 and 2026
Figure 72: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by Drug Coating Technology, 2018–2026
Figure 73: Middle East & Africa Drug Eluting Balloon Market Value Share, by End-user, 2017 and 2026
Figure 74: Middle East & Africa Drug Eluting Balloon Market Attractiveness, by End-user, 2018–2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes